

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 8.06691436 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 8.06691436 |
| 3 | negative regulation of glycogen biosynthetic process (GO:0045719) | 6.78108098 |
| 4 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 6.32305578 |
| 5 | branching involved in prostate gland morphogenesis (GO:0060442) | 5.74824943 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.66269648 |
| 7 | auditory receptor cell differentiation (GO:0042491) | 5.65387729 |
| 8 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.36436728 |
| 9 | cerebellar Purkinje cell layer development (GO:0021680) | 5.31050319 |
| 10 | angiotensin maturation (GO:0002003) | 5.30994147 |
| 11 | L-serine metabolic process (GO:0006563) | 5.29935057 |
| 12 | beta-amyloid metabolic process (GO:0050435) | 5.23265181 |
| 13 | NADH metabolic process (GO:0006734) | 5.17609897 |
| 14 | negative regulation of glycogen metabolic process (GO:0070874) | 5.17544551 |
| 15 | positive regulation of histone deacetylation (GO:0031065) | 5.09847179 |
| 16 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 5.01780520 |
| 17 | fatty acid elongation (GO:0030497) | 4.92195252 |
| 18 | copper ion transport (GO:0006825) | 4.84732431 |
| 19 | carnitine shuttle (GO:0006853) | 4.80266190 |
| 20 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.75934608 |
| 21 | myelin maintenance (GO:0043217) | 4.59456402 |
| 22 | drug transmembrane transport (GO:0006855) | 4.55774293 |
| 23 | phenol-containing compound catabolic process (GO:0019336) | 4.54785270 |
| 24 | regulation of endothelial cell chemotaxis (GO:2001026) | 4.48701665 |
| 25 | serine family amino acid biosynthetic process (GO:0009070) | 4.38735988 |
| 26 | cellular potassium ion homeostasis (GO:0030007) | 4.26869704 |
| 27 | fructose metabolic process (GO:0006000) | 4.26309495 |
| 28 | L-amino acid import (GO:0043092) | 4.26288396 |
| 29 | epithelial cell maturation (GO:0002070) | 4.17241572 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.15909085 |
| 31 | linoleic acid metabolic process (GO:0043651) | 4.08702345 |
| 32 | neurotransmitter catabolic process (GO:0042135) | 4.05487757 |
| 33 | COPI coating of Golgi vesicle (GO:0048205) | 4.05438886 |
| 34 | Golgi transport vesicle coating (GO:0048200) | 4.05438886 |
| 35 | replicative senescence (GO:0090399) | 4.01831658 |
| 36 | organic cation transport (GO:0015695) | 4.01716094 |
| 37 | myelination (GO:0042552) | 3.98462822 |
| 38 | axon ensheathment (GO:0008366) | 3.96110410 |
| 39 | ensheathment of neurons (GO:0007272) | 3.96110410 |
| 40 | urate metabolic process (GO:0046415) | 3.92702150 |
| 41 | sodium ion export (GO:0071436) | 3.90020848 |
| 42 | regulation of receptor binding (GO:1900120) | 3.88982726 |
| 43 | fatty acid transmembrane transport (GO:1902001) | 3.86918533 |
| 44 | cerebellar granule cell differentiation (GO:0021707) | 3.85970848 |
| 45 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.84898565 |
| 46 | response to mercury ion (GO:0046689) | 3.84252592 |
| 47 | carnitine transmembrane transport (GO:1902603) | 3.81229341 |
| 48 | negative regulation of glucose import (GO:0046325) | 3.80967690 |
| 49 | intestinal epithelial cell development (GO:0060576) | 3.78873431 |
| 50 | amino acid import (GO:0043090) | 3.78010749 |
| 51 | proline biosynthetic process (GO:0006561) | 3.77643295 |
| 52 | positive regulation of protein deacetylation (GO:0090312) | 3.66526294 |
| 53 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.65195951 |
| 54 | aspartate family amino acid catabolic process (GO:0009068) | 3.64849521 |
| 55 | drug transport (GO:0015893) | 3.61347827 |
| 56 | alkaloid metabolic process (GO:0009820) | 3.57206410 |
| 57 | phosphate ion transport (GO:0006817) | 3.57098937 |
| 58 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.55171094 |
| 59 | response to methylmercury (GO:0051597) | 3.51555957 |
| 60 | metanephric tubule development (GO:0072170) | 3.48284468 |
| 61 | metanephric nephron tubule development (GO:0072234) | 3.48284468 |
| 62 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.46143304 |
| 63 | regulation of cholesterol metabolic process (GO:0090181) | 3.45979963 |
| 64 | neurotransmitter uptake (GO:0001504) | 3.45314425 |
| 65 | potassium ion import (GO:0010107) | 3.44692801 |
| 66 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.41939955 |
| 67 | quaternary ammonium group transport (GO:0015697) | 3.41665020 |
| 68 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.40938087 |
| 69 | very long-chain fatty acid metabolic process (GO:0000038) | 3.39146441 |
| 70 | fatty acid beta-oxidation (GO:0006635) | 3.38506198 |
| 71 | L-phenylalanine catabolic process (GO:0006559) | 3.36005589 |
| 72 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.36005589 |
| 73 | establishment of mitochondrion localization (GO:0051654) | 3.33142634 |
| 74 | short-chain fatty acid metabolic process (GO:0046459) | 3.31315040 |
| 75 | sulfur amino acid catabolic process (GO:0000098) | 3.27782450 |
| 76 | response to lead ion (GO:0010288) | 3.27446949 |
| 77 | ER overload response (GO:0006983) | 3.26957229 |
| 78 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.26133024 |
| 79 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.25897630 |
| 80 | glutathione biosynthetic process (GO:0006750) | 3.25078439 |
| 81 | protein localization to synapse (GO:0035418) | 3.25035566 |
| 82 | prostate gland epithelium morphogenesis (GO:0060740) | 3.20216186 |
| 83 | creatine metabolic process (GO:0006600) | 3.18995514 |
| 84 | astrocyte differentiation (GO:0048708) | 3.18610629 |
| 85 | regulation of translational fidelity (GO:0006450) | 3.16922657 |
| 86 | glyoxylate metabolic process (GO:0046487) | 3.16487816 |
| 87 | excretion (GO:0007588) | 3.15829802 |
| 88 | import into cell (GO:0098657) | 3.14894275 |
| 89 | polyol transport (GO:0015791) | 3.14390672 |
| 90 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.13233971 |
| 91 | cellular sodium ion homeostasis (GO:0006883) | 3.11996451 |
| 92 | metanephric nephron epithelium development (GO:0072243) | 3.11556941 |
| 93 | C4-dicarboxylate transport (GO:0015740) | 3.09340045 |
| 94 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.09096765 |
| 95 | zinc ion transmembrane transport (GO:0071577) | 3.07420463 |
| 96 | phosphate ion transmembrane transport (GO:0035435) | 3.06203794 |
| 97 | negative regulation of JUN kinase activity (GO:0043508) | 3.02162424 |
| 98 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.01720369 |
| 99 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.01428947 |
| 100 | coenzyme A metabolic process (GO:0015936) | 3.00241872 |
| 101 | fatty acid catabolic process (GO:0009062) | 2.99986661 |
| 102 | potassium ion homeostasis (GO:0055075) | 2.99035223 |
| 103 | lysine metabolic process (GO:0006553) | 2.98904544 |
| 104 | lysine catabolic process (GO:0006554) | 2.98904544 |
| 105 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.98026547 |
| 106 | L-phenylalanine metabolic process (GO:0006558) | 2.98026547 |
| 107 | oxaloacetate metabolic process (GO:0006107) | 2.97938911 |
| 108 | negative regulation of neurotransmitter transport (GO:0051589) | 2.96138639 |
| 109 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.96026670 |
| 110 | biotin metabolic process (GO:0006768) | 2.95751339 |
| 111 | regulation of protein homodimerization activity (GO:0043496) | 2.95361156 |
| 112 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.94076495 |
| 113 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.91233655 |
| 114 | regulation of lipoprotein metabolic process (GO:0050746) | 2.90829092 |
| 115 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.90717053 |
| 116 | Golgi to plasma membrane transport (GO:0006893) | 2.90397437 |
| 117 | peptide biosynthetic process (GO:0043043) | 2.89995755 |
| 118 | response to lipoprotein particle (GO:0055094) | 2.89180377 |
| 119 | presynaptic membrane organization (GO:0097090) | 2.87246006 |
| 120 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.86960112 |
| 121 | regulation of histone deacetylation (GO:0031063) | 2.86349245 |
| 122 | thioester biosynthetic process (GO:0035384) | 2.86271763 |
| 123 | acyl-CoA biosynthetic process (GO:0071616) | 2.86271763 |
| 124 | fatty acid oxidation (GO:0019395) | 2.85701484 |
| 125 | zinc ion homeostasis (GO:0055069) | 2.85140045 |
| 126 | cellular response to electrical stimulus (GO:0071257) | 2.84618591 |
| 127 | metanephric epithelium development (GO:0072207) | 2.84200892 |
| 128 | branched-chain amino acid metabolic process (GO:0009081) | 2.83761179 |
| 129 | anterior/posterior axis specification, embryo (GO:0008595) | 2.83323949 |
| 130 | urea metabolic process (GO:0019627) | 2.82148171 |
| 131 | eye photoreceptor cell differentiation (GO:0001754) | 2.81909011 |
| 132 | photoreceptor cell differentiation (GO:0046530) | 2.81909011 |
| 133 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.81181628 |
| 134 | lipid oxidation (GO:0034440) | 2.80376835 |
| 135 | vitamin D metabolic process (GO:0042359) | 2.80098490 |
| 136 | triglyceride biosynthetic process (GO:0019432) | 2.79155758 |
| 137 | cell communication by electrical coupling (GO:0010644) | 2.79035398 |
| 138 | neurotransmitter biosynthetic process (GO:0042136) | 2.78405209 |
| 139 | carnitine metabolic process (GO:0009437) | 2.78203903 |
| 140 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.78080059 |
| 141 | response to testosterone (GO:0033574) | 2.77966427 |
| 142 | endocrine hormone secretion (GO:0060986) | 2.77436204 |
| 143 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 2.75606040 |
| 144 | artery development (GO:0060840) | 2.75015621 |
| 145 | negative regulation of glucose transport (GO:0010829) | 2.74218055 |
| 146 | cholesterol biosynthetic process (GO:0006695) | 2.74038282 |
| 147 | diaphragm development (GO:0060539) | 2.73557308 |
| 148 | purine ribonucleotide transport (GO:0015868) | 2.73448718 |
| 149 | urea cycle (GO:0000050) | 2.73118113 |
| 150 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.72769123 |
| 151 | branched-chain amino acid catabolic process (GO:0009083) | 2.71383395 |
| 152 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.70548882 |
| 153 | negative regulation of protein localization to cell surface (GO:2000009) | 2.70295651 |
| 154 | proline metabolic process (GO:0006560) | 2.70047916 |
| 155 | hair cell differentiation (GO:0035315) | 2.69963880 |
| 156 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.69817580 |
| 157 | presynaptic membrane assembly (GO:0097105) | 2.68936922 |
| 158 | dicarboxylic acid catabolic process (GO:0043649) | 2.68833841 |
| 159 | epoxygenase P450 pathway (GO:0019373) | 2.67410597 |
| 160 | desmosome organization (GO:0002934) | 2.67155976 |
| 161 | neutral lipid biosynthetic process (GO:0046460) | 2.65737436 |
| 162 | acylglycerol biosynthetic process (GO:0046463) | 2.65737436 |
| 163 | inner ear receptor cell differentiation (GO:0060113) | 2.65408762 |
| 164 | nucleotide transport (GO:0006862) | 2.65301803 |
| 165 | cysteine metabolic process (GO:0006534) | 2.65160660 |
| 166 | purine nucleotide transport (GO:0015865) | 2.64254956 |
| 167 | acetyl-CoA metabolic process (GO:0006084) | 2.59381259 |
| 168 | response to dietary excess (GO:0002021) | 2.57424063 |
| 169 | glycerol metabolic process (GO:0006071) | 2.57067614 |
| 170 | amino-acid betaine transport (GO:0015838) | 2.53879653 |
| 171 | carnitine transport (GO:0015879) | 2.53879653 |
| 172 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.53459425 |
| 173 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.53316898 |
| 174 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.53030945 |
| 175 | response to phenylpropanoid (GO:0080184) | 2.52464615 |
| 176 | oligodendrocyte differentiation (GO:0048709) | 2.51610002 |
| 177 | L-serine transport (GO:0015825) | 2.50953690 |
| 178 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.50218751 |
| 179 | renal absorption (GO:0070293) | 2.49564169 |
| 180 | gamma-aminobutyric acid transport (GO:0015812) | 2.49499166 |
| 181 | asymmetric protein localization (GO:0008105) | 2.48799418 |
| 182 | exogenous drug catabolic process (GO:0042738) | 2.48746173 |
| 183 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.48196773 |
| 184 | peripheral nervous system axon ensheathment (GO:0032292) | 2.48108377 |
| 185 | myelination in peripheral nervous system (GO:0022011) | 2.48108377 |
| 186 | iron ion import (GO:0097286) | 10.0072682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AR_21909140_ChIP-Seq_LNCAP_Human | 7.45464173 |
| 2 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 4.46505589 |
| 3 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 3.73298861 |
| 4 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.58911035 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.13846237 |
| 6 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.82870032 |
| 7 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.50512667 |
| 8 | CREB1_26743006_Chip-Seq_LNCaP_Human | 2.35488060 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.32367860 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.31636014 |
| 11 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.27358320 |
| 12 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 2.25921606 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.25818223 |
| 14 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.19736864 |
| 15 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.18975115 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.10989445 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.08574612 |
| 18 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.02161185 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01413130 |
| 20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.01329621 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.00833325 |
| 22 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.99258275 |
| 23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.95407637 |
| 24 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.94584549 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.93112584 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89719301 |
| 27 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.89644149 |
| 28 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.89288735 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.87799720 |
| 30 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.86602611 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.86602611 |
| 32 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85430214 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.79540493 |
| 34 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.75657690 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.73633415 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.68969344 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.67438755 |
| 38 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65330834 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64580529 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.61184450 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.60330281 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.59745443 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57138860 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.54927553 |
| 45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.53978061 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50293847 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48168446 |
| 48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47194947 |
| 49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.44719694 |
| 50 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.44266654 |
| 51 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.43578161 |
| 52 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39586751 |
| 53 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.39092388 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37862110 |
| 55 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.37224633 |
| 56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36910607 |
| 57 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36567025 |
| 58 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36363751 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33802389 |
| 60 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33559728 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33376717 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.33218360 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33041134 |
| 64 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32936003 |
| 65 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.32327166 |
| 66 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.31868993 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.30396685 |
| 68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.30055976 |
| 69 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29931449 |
| 70 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.29875844 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27812930 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27812930 |
| 73 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27567739 |
| 74 | * AR_21572438_ChIP-Seq_LNCaP_Human | 1.26784499 |
| 75 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25462975 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24009952 |
| 77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24009612 |
| 78 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22947935 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.22403226 |
| 80 | * RXR_22108803_ChIP-Seq_LS180_Human | 1.22160871 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.22135909 |
| 82 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22046460 |
| 83 | * VDR_22108803_ChIP-Seq_LS180_Human | 1.19982013 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18879355 |
| 85 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18820461 |
| 86 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18474746 |
| 87 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.17927897 |
| 88 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17878400 |
| 89 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.17371820 |
| 90 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16869227 |
| 91 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.16640457 |
| 92 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.16640457 |
| 93 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.16640457 |
| 94 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16055814 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15936666 |
| 96 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.15651416 |
| 97 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14443023 |
| 98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13774387 |
| 99 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13151878 |
| 100 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.12514407 |
| 101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12395519 |
| 102 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12309377 |
| 103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12130941 |
| 104 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.11668567 |
| 105 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11611061 |
| 106 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11118454 |
| 107 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.10803716 |
| 108 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10468804 |
| 109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10353950 |
| 110 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.09620191 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09485831 |
| 112 | AR_25329375_ChIP-Seq_VCAP_Human | 1.07740766 |
| 113 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07685942 |
| 114 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07492201 |
| 115 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07294953 |
| 116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07123907 |
| 117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06604295 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06348015 |
| 119 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05869689 |
| 120 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.05331473 |
| 121 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05218114 |
| 122 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05067713 |
| 123 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04676404 |
| 124 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04550241 |
| 125 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04320472 |
| 126 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03785491 |
| 127 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01565709 |
| 128 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01159019 |
| 129 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.01146341 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00691246 |
| 131 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.00392796 |
| 132 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.00346307 |
| 133 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99512753 |
| 134 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99401332 |
| 135 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98930493 |
| 136 | MYC_22102868_ChIP-Seq_BL_Human | 0.97986029 |
| 137 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.97518308 |
| 138 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97256366 |
| 139 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96890955 |
| 140 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96623232 |
| 141 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96481008 |
| 142 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96060244 |
| 143 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95880486 |
| 144 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.95875276 |
| 145 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95741505 |
| 146 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95648023 |
| 147 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94693288 |
| 148 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94248320 |
| 149 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93537098 |
| 150 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.92404193 |
| 151 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.91407485 |
| 152 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90821116 |
| 153 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90275211 |
| 154 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90275211 |
| 155 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90037318 |
| 156 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.89803243 |
| 157 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89566948 |
| 158 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.89487209 |
| 159 | GATA1_22025678_ChIP-Seq_K562_Human | 0.89413516 |
| 160 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.89041020 |
| 161 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88487711 |
| 162 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87343143 |
| 163 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.87306304 |
| 164 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.87082195 |
| 165 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86577151 |
| 166 | TCF4_23295773_ChIP-Seq_U87_Human | 0.86321604 |
| 167 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85811957 |
| 168 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.85725418 |
| 169 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85114960 |
| 170 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85109297 |
| 171 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.84903315 |
| 172 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84668818 |
| 173 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.84640508 |
| 174 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.82770118 |
| 175 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82496844 |
| 176 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.79698060 |
| 177 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.78728588 |
| 178 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.78118188 |
| 179 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.77756797 |
| 180 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.76299559 |
| 181 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74942533 |
| 182 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.73944034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003123_paternal_imprinting | 5.14429298 |
| 2 | MP0004043_abnormal_pH_regulation | 4.97204737 |
| 3 | MP0002009_preneoplasia | 4.85307557 |
| 4 | MP0000537_abnormal_urethra_morphology | 4.42119379 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.71380473 |
| 6 | MP0004233_abnormal_muscle_weight | 3.44660939 |
| 7 | MP0002166_altered_tumor_susceptibility | 3.42747196 |
| 8 | MP0003136_yellow_coat_color | 3.39472073 |
| 9 | MP0000920_abnormal_myelination | 3.28129442 |
| 10 | MP0003690_abnormal_glial_cell | 3.25669091 |
| 11 | MP0004885_abnormal_endolymph | 3.23776254 |
| 12 | MP0002822_catalepsy | 3.03382795 |
| 13 | MP0005360_urolithiasis | 3.03062851 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.89328650 |
| 15 | MP0005647_abnormal_sex_gland | 2.79536438 |
| 16 | MP0003315_abnormal_perineum_morphology | 2.78348547 |
| 17 | MP0005332_abnormal_amino_acid | 2.72334261 |
| 18 | MP0003195_calcinosis | 2.64755468 |
| 19 | MP0004270_analgesia | 2.63632997 |
| 20 | * MP0004858_abnormal_nervous_system | 2.62339248 |
| 21 | MP0003950_abnormal_plasma_membrane | 2.51565488 |
| 22 | MP0003329_amyloid_beta_deposits | 2.49900221 |
| 23 | MP0002006_tumorigenesis | 2.37243944 |
| 24 | MP0005377_hearing/vestibular/ear_phenot | 2.32491712 |
| 25 | MP0003878_abnormal_ear_physiology | 2.32491712 |
| 26 | MP0004264_abnormal_extraembryonic_tissu | 2.28083320 |
| 27 | MP0003880_abnormal_central_pattern | 2.24110969 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 2.23166938 |
| 29 | MP0005171_absent_coat_pigmentation | 2.19747219 |
| 30 | MP0005310_abnormal_salivary_gland | 2.03846466 |
| 31 | MP0001765_abnormal_ion_homeostasis | 2.03548942 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.94291859 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.93301101 |
| 34 | MP0001666_abnormal_nutrient_absorption | 1.90197560 |
| 35 | MP0001485_abnormal_pinna_reflex | 1.89975725 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.89824325 |
| 37 | MP0005423_abnormal_somatic_nervous | 1.86886761 |
| 38 | MP0001486_abnormal_startle_reflex | 1.85455717 |
| 39 | MP0004947_skin_inflammation | 1.84002051 |
| 40 | MP0004742_abnormal_vestibular_system | 1.81760504 |
| 41 | MP0003634_abnormal_glial_cell | 1.79101463 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.76799084 |
| 43 | MP0001958_emphysema | 1.76320649 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.75365157 |
| 45 | MP0001873_stomach_inflammation | 1.72319628 |
| 46 | MP0003879_abnormal_hair_cell | 1.71731222 |
| 47 | MP0000627_abnormal_mammary_gland | 1.65597671 |
| 48 | MP0005670_abnormal_white_adipose | 1.60197565 |
| 49 | MP0002139_abnormal_hepatobiliary_system | 1.58764312 |
| 50 | MP0002064_seizures | 1.57717764 |
| 51 | MP0005365_abnormal_bile_salt | 1.53828548 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.53660087 |
| 53 | MP0002272_abnormal_nervous_system | 1.51546416 |
| 54 | MP0009046_muscle_twitch | 1.49838783 |
| 55 | MP0003633_abnormal_nervous_system | 1.48899364 |
| 56 | MP0000613_abnormal_salivary_gland | 1.46344999 |
| 57 | MP0000538_abnormal_urinary_bladder | 1.44897811 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.44530183 |
| 59 | MP0005409_darkened_coat_color | 1.39594697 |
| 60 | MP0004142_abnormal_muscle_tone | 1.39534836 |
| 61 | MP0004147_increased_porphyrin_level | 1.38037377 |
| 62 | MP0001881_abnormal_mammary_gland | 1.36920352 |
| 63 | MP0001440_abnormal_grooming_behavior | 1.36552228 |
| 64 | MP0001764_abnormal_homeostasis | 1.35778741 |
| 65 | MP0001756_abnormal_urination | 1.34195703 |
| 66 | MP0003631_nervous_system_phenotype | 1.34033365 |
| 67 | MP0002229_neurodegeneration | 1.33571564 |
| 68 | MP0002876_abnormal_thyroid_physiology | 1.32219378 |
| 69 | MP0003718_maternal_effect | 1.31859502 |
| 70 | MP0009384_cardiac_valve_regurgitation | 1.31711609 |
| 71 | MP0000604_amyloidosis | 1.29833847 |
| 72 | MP0003121_genomic_imprinting | 1.29544209 |
| 73 | MP0005410_abnormal_fertilization | 1.28340663 |
| 74 | MP0000778_abnormal_nervous_system | 1.22001393 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 1.20999254 |
| 76 | MP0003632_abnormal_nervous_system | 1.20887679 |
| 77 | MP0001905_abnormal_dopamine_level | 1.20708966 |
| 78 | MP0002734_abnormal_mechanical_nocicepti | 1.19943137 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 1.19285178 |
| 80 | MP0001661_extended_life_span | 1.19182015 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.18770328 |
| 82 | MP0001919_abnormal_reproductive_system | 1.18437784 |
| 83 | MP0002249_abnormal_larynx_morphology | 1.18038620 |
| 84 | MP0002136_abnormal_kidney_physiology | 1.16974578 |
| 85 | MP0003635_abnormal_synaptic_transmissio | 1.16916833 |
| 86 | MP0009745_abnormal_behavioral_response | 1.16714448 |
| 87 | MP0005666_abnormal_adipose_tissue | 1.12709758 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 1.12258383 |
| 89 | MP0000566_synostosis | 1.11052066 |
| 90 | MP0001963_abnormal_hearing_physiology | 1.09839745 |
| 91 | MP0000516_abnormal_urinary_system | 1.09368915 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 1.09368915 |
| 93 | MP0002067_abnormal_sensory_capabilities | 1.08942020 |
| 94 | MP0004859_abnormal_synaptic_plasticity | 1.08783225 |
| 95 | MP0005646_abnormal_pituitary_gland | 1.04501354 |
| 96 | MP0005551_abnormal_eye_electrophysiolog | 1.02266966 |
| 97 | MP0000377_abnormal_hair_follicle | 1.02234158 |
| 98 | MP0001529_abnormal_vocalization | 1.01501712 |
| 99 | MP0009840_abnormal_foam_cell | 0.99299120 |
| 100 | MP0003959_abnormal_lean_body | 0.98887318 |
| 101 | MP0002736_abnormal_nociception_after | 0.98259213 |
| 102 | MP0002063_abnormal_learning/memory/cond | 0.96804700 |
| 103 | MP0000747_muscle_weakness | 0.96785778 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 0.96558048 |
| 105 | MP0002090_abnormal_vision | 0.95331444 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94689847 |
| 107 | MP0005220_abnormal_exocrine_pancreas | 0.94592517 |
| 108 | MP0002098_abnormal_vibrissa_morphology | 0.94256977 |
| 109 | MP0003186_abnormal_redox_activity | 0.94025590 |
| 110 | MP0005395_other_phenotype | 0.93589874 |
| 111 | MP0003936_abnormal_reproductive_system | 0.93385584 |
| 112 | MP0002796_impaired_skin_barrier | 0.92364215 |
| 113 | MP0003941_abnormal_skin_development | 0.91995019 |
| 114 | MP0008260_abnormal_autophagy | 0.91667818 |
| 115 | MP0002066_abnormal_motor_capabilities/c | 0.91125542 |
| 116 | MP0003868_abnormal_feces_composition | 0.89328126 |
| 117 | MP0002118_abnormal_lipid_homeostasis | 0.88445461 |
| 118 | * MP0002572_abnormal_emotion/affect_behav | 0.87452863 |
| 119 | MP0001968_abnormal_touch/_nociception | 0.86229091 |
| 120 | MP0008569_lethality_at_weaning | 0.86014524 |
| 121 | MP0005535_abnormal_body_temperature | 0.85797877 |
| 122 | MP0005451_abnormal_body_composition | 0.85269181 |
| 123 | MP0010352_gastrointestinal_tract_polyps | 0.82419984 |
| 124 | MP0001177_atelectasis | 0.82061942 |
| 125 | MP0003011_delayed_dark_adaptation | 0.82048358 |
| 126 | MP0005187_abnormal_penis_morphology | 0.81626495 |
| 127 | MP0005375_adipose_tissue_phenotype | 0.81358133 |
| 128 | MP0002735_abnormal_chemical_nociception | 0.80670342 |
| 129 | MP0001970_abnormal_pain_threshold | 0.80547809 |
| 130 | MP0002882_abnormal_neuron_morphology | 0.79463668 |
| 131 | MP0000026_abnormal_inner_ear | 0.79360934 |
| 132 | * MP0000230_abnormal_systemic_arterial | 0.77554504 |
| 133 | MP0004134_abnormal_chest_morphology | 0.76030551 |
| 134 | MP0005386_behavior/neurological_phenoty | 0.74305417 |
| 135 | MP0004924_abnormal_behavior | 0.74305417 |
| 136 | MP0000534_abnormal_ureter_morphology | 0.71434323 |
| 137 | MP0001501_abnormal_sleep_pattern | 0.71081838 |
| 138 | MP0002733_abnormal_thermal_nociception | 0.69674219 |
| 139 | MP0002909_abnormal_adrenal_gland | 0.65887708 |
| 140 | MP0002168_other_aberrant_phenotype | 0.63180475 |
| 141 | MP0005167_abnormal_blood-brain_barrier | 0.63110817 |
| 142 | MP0001664_abnormal_digestion | 0.63056403 |
| 143 | MP0010678_abnormal_skin_adnexa | 0.61647867 |
| 144 | MP0003137_abnormal_impulse_conducting | 0.60223373 |
| 145 | MP0006138_congestive_heart_failure | 0.59640397 |
| 146 | MP0003938_abnormal_ear_development | 0.59627604 |
| 147 | MP0005319_abnormal_enzyme/_coenzyme | 0.59598230 |
| 148 | MP0002295_abnormal_pulmonary_circulatio | 0.59389426 |
| 149 | MP0000955_abnormal_spinal_cord | 0.59219877 |
| 150 | MP0002557_abnormal_social/conspecific_i | 0.58987905 |
| 151 | MP0004130_abnormal_muscle_cell | 0.58970792 |
| 152 | * MP0002752_abnormal_somatic_nervous | 0.57840796 |
| 153 | MP0001502_abnormal_circadian_rhythm | 0.57724815 |
| 154 | MP0001944_abnormal_pancreas_morphology | 0.57179724 |
| 155 | MP0000609_abnormal_liver_physiology | 0.54907710 |
| 156 | MP0001731_abnormal_postnatal_growth | 0.54246450 |
| 157 | MP0002078_abnormal_glucose_homeostasis | 0.52941361 |
| 158 | MP0003045_fibrosis | 0.50854251 |
| 159 | MP0004197_abnormal_fetal_growth/weight/ | 0.49701948 |
| 160 | MP0003953_abnormal_hormone_level | 0.49619669 |
| 161 | MP0001216_abnormal_epidermal_layer | 0.49532430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 7.12501401 |
| 2 | Sparse lateral eyebrow (HP:0005338) | 6.86028830 |
| 3 | Metabolic alkalosis (HP:0200114) | 6.58016299 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 6.41537796 |
| 5 | Hypomagnesemia (HP:0002917) | 5.92760401 |
| 6 | Neonatal hypoglycemia (HP:0001998) | 5.91448207 |
| 7 | Abnormality of the axillary hair (HP:0100134) | 5.60316471 |
| 8 | Abnormality of secondary sexual hair (HP:0009888) | 5.60316471 |
| 9 | Polyuria (HP:0000103) | 5.18397630 |
| 10 | Abnormal urine output (HP:0012590) | 5.04197005 |
| 11 | Obstructive sleep apnea (HP:0002870) | 4.84440570 |
| 12 | Abnormality of magnesium homeostasis (HP:0004921) | 4.75630872 |
| 13 | Abnormality of renal excretion (HP:0011036) | 4.67960434 |
| 14 | Hyperactive renin-angiotensin system (HP:0000841) | 4.59952747 |
| 15 | Polydipsia (HP:0001959) | 4.54817795 |
| 16 | Abnormal drinking behavior (HP:0030082) | 4.54817795 |
| 17 | Neurofibrillary tangles (HP:0002185) | 4.51085146 |
| 18 | Prostate neoplasm (HP:0100787) | 4.21637857 |
| 19 | Abnormality of chloride homeostasis (HP:0011422) | 4.19756962 |
| 20 | Germ cell neoplasia (HP:0100728) | 4.17422130 |
| 21 | Lip pit (HP:0100267) | 4.15132612 |
| 22 | Gonadotropin excess (HP:0000837) | 3.98927409 |
| 23 | Hyperaldosteronism (HP:0000859) | 3.93584469 |
| 24 | Abnormality of the fingertips (HP:0001211) | 3.93145410 |
| 25 | Renal salt wasting (HP:0000127) | 3.90469563 |
| 26 | Abnormality of renin-angiotensin system (HP:0000847) | 3.88814797 |
| 27 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.80631075 |
| 28 | Alkalosis (HP:0001948) | 3.69818740 |
| 29 | Testicular atrophy (HP:0000029) | 3.69724094 |
| 30 | Azoospermia (HP:0000027) | 3.64042294 |
| 31 | Depressed nasal tip (HP:0000437) | 3.58549535 |
| 32 | Gout (HP:0001997) | 3.56789263 |
| 33 | Dysmetric saccades (HP:0000641) | 3.52930591 |
| 34 | Calf muscle hypertrophy (HP:0008981) | 3.52323122 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.49293681 |
| 36 | Hyperammonemia (HP:0001987) | 3.48322125 |
| 37 | Overgrowth (HP:0001548) | 3.45097415 |
| 38 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.43125906 |
| 39 | Aplasia of the phalanges of the hand (HP:0009802) | 3.43125906 |
| 40 | Aplasia involving bones of the extremities (HP:0009825) | 3.43125906 |
| 41 | Proximal tubulopathy (HP:0000114) | 3.40721276 |
| 42 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.35479383 |
| 43 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.35479383 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 3.32552894 |
| 45 | Hyperglycinuria (HP:0003108) | 3.24365633 |
| 46 | Tetany (HP:0001281) | 3.23845116 |
| 47 | Abnormal auditory evoked potentials (HP:0006958) | 3.16376156 |
| 48 | Confusion (HP:0001289) | 3.15961463 |
| 49 | Abnormality of glycine metabolism (HP:0010895) | 3.12422072 |
| 50 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.12422072 |
| 51 | Aplasia of the musculature (HP:0100854) | 3.04648129 |
| 52 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.01867993 |
| 53 | Advanced eruption of teeth (HP:0006288) | 2.98570897 |
| 54 | Intrahepatic cholestasis (HP:0001406) | 2.94616677 |
| 55 | Amelogenesis imperfecta (HP:0000705) | 2.92105746 |
| 56 | Hypokalemia (HP:0002900) | 2.90434234 |
| 57 | Limb hypertonia (HP:0002509) | 2.88166426 |
| 58 | Fat malabsorption (HP:0002630) | 2.87697382 |
| 59 | Death in childhood (HP:0003819) | 2.71264761 |
| 60 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.69620836 |
| 61 | Shallow orbits (HP:0000586) | 2.65700790 |
| 62 | Anal stenosis (HP:0002025) | 2.65089040 |
| 63 | Long palpebral fissure (HP:0000637) | 2.64553436 |
| 64 | Hyperuricemia (HP:0002149) | 2.62250555 |
| 65 | Increased purine levels (HP:0004368) | 2.62250555 |
| 66 | Glossoptosis (HP:0000162) | 2.59713507 |
| 67 | Ketoacidosis (HP:0001993) | 2.56256307 |
| 68 | Supranuclear gaze palsy (HP:0000605) | 2.55391952 |
| 69 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.53254687 |
| 70 | Renal tubular acidosis (HP:0001947) | 2.48038213 |
| 71 | Abnormality of potassium homeostasis (HP:0011042) | 2.46364780 |
| 72 | Abnormality of the corticospinal tract (HP:0002492) | 2.46344146 |
| 73 | Onion bulb formation (HP:0003383) | 2.45348675 |
| 74 | Flat acetabular roof (HP:0003180) | 2.44401630 |
| 75 | Bulbar palsy (HP:0001283) | 2.39454198 |
| 76 | Hypothermia (HP:0002045) | 2.38051930 |
| 77 | Testicular neoplasm (HP:0010788) | 2.37489839 |
| 78 | Potter facies (HP:0002009) | 2.35065844 |
| 79 | Facial shape deformation (HP:0011334) | 2.35065844 |
| 80 | Axonal loss (HP:0003447) | 2.34778366 |
| 81 | Bifid scrotum (HP:0000048) | 2.33633369 |
| 82 | Abnormal spermatogenesis (HP:0008669) | 2.32638174 |
| 83 | Right ventricular cardiomyopathy (HP:0011663) | 2.32225277 |
| 84 | Hypercalciuria (HP:0002150) | 2.31102504 |
| 85 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.28866954 |
| 86 | Abnormality of homocysteine metabolism (HP:0010919) | 2.28730444 |
| 87 | Homocystinuria (HP:0002156) | 2.28730444 |
| 88 | Malnutrition (HP:0004395) | 2.27529685 |
| 89 | Pheochromocytoma (HP:0002666) | 2.23685983 |
| 90 | Broad face (HP:0000283) | 2.20906394 |
| 91 | Synostosis involving the elbow (HP:0003938) | 2.19976797 |
| 92 | Humeroradial synostosis (HP:0003041) | 2.19976797 |
| 93 | Macroorchidism (HP:0000053) | 2.18191547 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.18107386 |
| 95 | Hypoglycemic coma (HP:0001325) | 2.17128154 |
| 96 | Precocious puberty (HP:0000826) | 2.15393877 |
| 97 | Metabolic acidosis (HP:0001942) | 2.13737366 |
| 98 | Seborrheic dermatitis (HP:0001051) | 2.13645162 |
| 99 | Generalized aminoaciduria (HP:0002909) | 2.12069854 |
| 100 | Abnormality of binocular vision (HP:0011514) | 2.10524169 |
| 101 | Diplopia (HP:0000651) | 2.10524169 |
| 102 | Glycosuria (HP:0003076) | 2.10335439 |
| 103 | Abnormality of urine glucose concentration (HP:0011016) | 2.10335439 |
| 104 | Abnormality of purine metabolism (HP:0004352) | 2.10193851 |
| 105 | Abnormal pupillary function (HP:0007686) | 2.09566274 |
| 106 | Peripheral hypomyelination (HP:0007182) | 2.07841649 |
| 107 | Vascular calcification (HP:0004934) | 2.07739029 |
| 108 | Hypophosphatemic rickets (HP:0004912) | 2.07512575 |
| 109 | Abnormal eating behavior (HP:0100738) | 2.07458121 |
| 110 | Laryngomalacia (HP:0001601) | 2.07419650 |
| 111 | Abnormality of the parathyroid morphology (HP:0011766) | 2.07206648 |
| 112 | Rickets (HP:0002748) | 2.06860435 |
| 113 | Abnormality of renal resorption (HP:0011038) | 2.06782546 |
| 114 | Hyperglycinemia (HP:0002154) | 2.06383484 |
| 115 | Sleep apnea (HP:0010535) | 2.05380492 |
| 116 | Ketosis (HP:0001946) | 2.02582438 |
| 117 | Absent hair (HP:0002298) | 2.02427357 |
| 118 | Clumsiness (HP:0002312) | 2.01382300 |
| 119 | Skin pits (HP:0100276) | 2.01270078 |
| 120 | Exercise-induced myalgia (HP:0003738) | 1.99998973 |
| 121 | Hypoplasia of the odontoid process (HP:0003311) | 1.99867944 |
| 122 | Paraparesis (HP:0002385) | 1.99740559 |
| 123 | Parakeratosis (HP:0001036) | 1.99595373 |
| 124 | Enlarged kidneys (HP:0000105) | 1.99363091 |
| 125 | Hypoplastic left heart (HP:0004383) | 1.99072625 |
| 126 | Impulsivity (HP:0100710) | 1.97745669 |
| 127 | Intention tremor (HP:0002080) | 1.97484453 |
| 128 | Widely patent fontanelles and sutures (HP:0004492) | 1.96535921 |
| 129 | Limb ataxia (HP:0002070) | 1.96448509 |
| 130 | Dysmetria (HP:0001310) | 1.94185336 |
| 131 | Breast hypoplasia (HP:0003187) | 1.92504682 |
| 132 | Hypoplasia of the iris (HP:0007676) | 1.91743009 |
| 133 | Neuroendocrine neoplasm (HP:0100634) | 1.89866471 |
| 134 | Papilledema (HP:0001085) | 1.89752924 |
| 135 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.89312345 |
| 136 | Hemiparesis (HP:0001269) | 1.87902524 |
| 137 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.87179108 |
| 138 | Broad nasal tip (HP:0000455) | 1.86056666 |
| 139 | Nephrocalcinosis (HP:0000121) | 1.85497384 |
| 140 | Morphological abnormality of the inner ear (HP:0011390) | 1.84459062 |
| 141 | Abnormally folded helix (HP:0008544) | 1.84381485 |
| 142 | Pseudobulbar signs (HP:0002200) | 1.82486475 |
| 143 | Cardiovascular calcification (HP:0011915) | 1.81596670 |
| 144 | Spastic paraparesis (HP:0002313) | 1.80704723 |
| 145 | Abnormal urine phosphate concentration (HP:0012599) | 1.79904880 |
| 146 | Megalencephaly (HP:0001355) | 1.79142343 |
| 147 | Abnormality of permanent molar morphology (HP:0011071) | 1.78587557 |
| 148 | Abnormality of the dental root (HP:0006486) | 1.78587557 |
| 149 | Taurodontia (HP:0000679) | 1.78587557 |
| 150 | Choanal stenosis (HP:0000452) | 1.76869121 |
| 151 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.74182633 |
| 152 | Leukodystrophy (HP:0002415) | 1.73282639 |
| 153 | Hyperphosphaturia (HP:0003109) | 1.72922777 |
| 154 | Partial agenesis of the corpus callosum (HP:0001338) | 1.72873089 |
| 155 | Blue sclerae (HP:0000592) | 1.72125160 |
| 156 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.71630069 |
| 157 | Delayed epiphyseal ossification (HP:0002663) | 1.71567235 |
| 158 | Abnormality of glycolysis (HP:0004366) | 1.71464586 |
| 159 | Tubulointerstitial fibrosis (HP:0005576) | 1.71193750 |
| 160 | Abnormality of the dental pulp (HP:0006479) | 1.71183002 |
| 161 | Stridor (HP:0010307) | 1.70407022 |
| 162 | Thin bony cortex (HP:0002753) | 1.70177117 |
| 163 | Abnormality of the columella (HP:0009929) | 1.69740625 |
| 164 | Abnormality of molar morphology (HP:0011070) | 1.69247174 |
| 165 | Abnormality of molar (HP:0011077) | 1.69247174 |
| 166 | Split foot (HP:0001839) | 1.68859502 |
| 167 | Hyperlipoproteinemia (HP:0010980) | 1.68585866 |
| 168 | Overfolded helix (HP:0000396) | 1.68126030 |
| 169 | Cerebral hemorrhage (HP:0001342) | 1.67761243 |
| 170 | Ankle clonus (HP:0011448) | 1.66765630 |
| 171 | Short hallux (HP:0010109) | 1.66697355 |
| 172 | Termporal pattern (HP:0011008) | 1.66372668 |
| 173 | Neonatal death (HP:0003811) | 1.66199728 |
| 174 | Severe short stature (HP:0003510) | 1.63176250 |
| 175 | Congenital stationary night blindness (HP:0007642) | 1.62729475 |
| 176 | Absent hand (HP:0004050) | 1.61088372 |
| 177 | Steatorrhea (HP:0002570) | 1.60794710 |
| 178 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.60475526 |
| 179 | Abnormality of the prostate (HP:0008775) | 1.59195022 |
| 180 | Thoracic kyphosis (HP:0002942) | 1.58887250 |
| 181 | Abnormality of the thoracic spine (HP:0100711) | 1.58479534 |
| 182 | Fasciculations (HP:0002380) | 1.58349809 |
| 183 | Abnormality of vitamin metabolism (HP:0100508) | 1.57642049 |
| 184 | Hyperphosphatemia (HP:0002905) | 1.57533108 |
| 185 | Prolonged neonatal jaundice (HP:0006579) | 1.57502028 |
| 186 | Hyperthyroidism (HP:0000836) | 1.57471595 |
| 187 | Truncal ataxia (HP:0002078) | 1.57251933 |
| 188 | Shawl scrotum (HP:0000049) | 1.56623094 |
| 189 | Neoplasm of the adrenal cortex (HP:0100641) | 1.56550941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 7.23027976 |
| 2 | OXSR1 | 6.46843680 |
| 3 | STK39 | 6.19525602 |
| 4 | WNK4 | 5.79298710 |
| 5 | WNK3 | 4.03374594 |
| 6 | TNK2 | 3.38020003 |
| 7 | EEF2K | 3.16477188 |
| 8 | TRIB3 | 2.89892641 |
| 9 | TAF1 | 2.72099438 |
| 10 | ICK | 2.45417269 |
| 11 | SMG1 | 2.44545422 |
| 12 | EPHB1 | 2.32081718 |
| 13 | WNK1 | 2.15842160 |
| 14 | SGK494 | 2.13052623 |
| 15 | SGK223 | 2.13052623 |
| 16 | MAPKAPK5 | 2.08372754 |
| 17 | PRKD3 | 1.83617005 |
| 18 | GRK1 | 1.75633916 |
| 19 | MET | 1.68121355 |
| 20 | FGFR2 | 1.62186211 |
| 21 | NEK6 | 1.61196793 |
| 22 | TNIK | 1.59855416 |
| 23 | PKN1 | 1.58358030 |
| 24 | MST4 | 1.54265281 |
| 25 | NTRK1 | 1.49974131 |
| 26 | BCR | 1.44897170 |
| 27 | TESK2 | 1.43170586 |
| 28 | SIK1 | 1.38092995 |
| 29 | PKN2 | 1.34185836 |
| 30 | EPHA4 | 1.24551710 |
| 31 | PHKG2 | 1.24168733 |
| 32 | PHKG1 | 1.24168733 |
| 33 | MAPK12 | 1.23803434 |
| 34 | PBK | 1.21545144 |
| 35 | CASK | 1.21332601 |
| 36 | EIF2AK1 | 1.13153961 |
| 37 | PDK2 | 1.03650411 |
| 38 | BRSK2 | 1.00439618 |
| 39 | ERN1 | 0.99834770 |
| 40 | CAMKK2 | 0.99328478 |
| 41 | CAMK1G | 0.98207888 |
| 42 | CAMK2B | 0.97406449 |
| 43 | LATS1 | 0.97163343 |
| 44 | PINK1 | 0.96056584 |
| 45 | LMTK2 | 0.95978204 |
| 46 | PNCK | 0.93021578 |
| 47 | ROCK2 | 0.91707480 |
| 48 | BCKDK | 0.89811186 |
| 49 | VRK2 | 0.89137112 |
| 50 | PDK4 | 0.88742689 |
| 51 | PDK3 | 0.88742689 |
| 52 | MAPK13 | 0.87766383 |
| 53 | PAK3 | 0.86343544 |
| 54 | UHMK1 | 0.85262192 |
| 55 | PRKCE | 0.84315535 |
| 56 | PIK3CA | 0.83281122 |
| 57 | MAPK7 | 0.81688791 |
| 58 | MUSK | 0.81633253 |
| 59 | NEK9 | 0.81628108 |
| 60 | PDPK1 | 0.80965655 |
| 61 | PAK6 | 0.78524223 |
| 62 | SCYL2 | 0.78440835 |
| 63 | FGR | 0.77758334 |
| 64 | PRKD2 | 0.76428677 |
| 65 | CAMK2G | 0.76262759 |
| 66 | NTRK2 | 0.74771439 |
| 67 | CAMKK1 | 0.74507039 |
| 68 | CDK7 | 0.74186723 |
| 69 | CDK19 | 0.73539170 |
| 70 | TAOK1 | 0.71898595 |
| 71 | CAMK2D | 0.69978046 |
| 72 | EPHA2 | 0.69776930 |
| 73 | MARK1 | 0.68723207 |
| 74 | EPHA3 | 0.68253020 |
| 75 | MARK2 | 0.68245732 |
| 76 | CAMK2A | 0.67434271 |
| 77 | CDK5 | 0.67162214 |
| 78 | LATS2 | 0.65062602 |
| 79 | MTOR | 0.64995436 |
| 80 | PRKD1 | 0.64934824 |
| 81 | CAMK1D | 0.64425066 |
| 82 | GSK3A | 0.63033551 |
| 83 | LIMK1 | 0.60234718 |
| 84 | PAK2 | 0.59541150 |
| 85 | SGK1 | 0.57338405 |
| 86 | MAPKAPK3 | 0.56975513 |
| 87 | CDK12 | 0.55986069 |
| 88 | CSNK1G1 | 0.55399755 |
| 89 | CSNK1G2 | 0.54773927 |
| 90 | PRKCG | 0.54664827 |
| 91 | PRKCQ | 0.54090604 |
| 92 | SGK2 | 0.54044148 |
| 93 | NUAK1 | 0.52255303 |
| 94 | NTRK3 | 0.52142733 |
| 95 | IRAK2 | 0.51461793 |
| 96 | PTK6 | 0.51438083 |
| 97 | MAP3K2 | 0.50869789 |
| 98 | PDK1 | 0.50854254 |
| 99 | HIPK2 | 0.50526208 |
| 100 | ERBB4 | 0.50425147 |
| 101 | CSNK1A1L | 0.49958999 |
| 102 | PRKCH | 0.49815146 |
| 103 | CSNK1G3 | 0.48866273 |
| 104 | SGK3 | 0.46903132 |
| 105 | TIE1 | 0.46114099 |
| 106 | MAP2K4 | 0.43525362 |
| 107 | PRKAA2 | 0.42901896 |
| 108 | MST1R | 0.41961160 |
| 109 | CDK14 | 0.41462780 |
| 110 | KSR2 | 0.40153127 |
| 111 | TYRO3 | 0.40095175 |
| 112 | PRKACB | 0.39452884 |
| 113 | MAP3K13 | 0.39363843 |
| 114 | CDK15 | 0.38729566 |
| 115 | STK38 | 0.38566247 |
| 116 | PTK2B | 0.38453204 |
| 117 | PRKACA | 0.38413468 |
| 118 | CSNK1A1 | 0.37818823 |
| 119 | MAP2K7 | 0.37786754 |
| 120 | MINK1 | 0.37416502 |
| 121 | FER | 0.37410262 |
| 122 | ILK | 0.37196308 |
| 123 | TSSK6 | 0.35728310 |
| 124 | FYN | 0.34481275 |
| 125 | CDK18 | 0.33633346 |
| 126 | MAPK15 | 0.33632466 |
| 127 | DYRK1A | 0.33425624 |
| 128 | PRKCA | 0.32659303 |
| 129 | CLK1 | 0.32082214 |
| 130 | PRKCZ | 0.31203305 |
| 131 | PRKAA1 | 0.31179666 |
| 132 | ARAF | 0.30522137 |
| 133 | BRSK1 | 0.30469168 |
| 134 | INSRR | 0.30051969 |
| 135 | IRAK3 | 0.30042076 |
| 136 | BMX | 0.30014417 |
| 137 | CDK11A | 0.29416643 |
| 138 | LRRK2 | 0.29293323 |
| 139 | RPS6KA2 | 0.29227361 |
| 140 | RPS6KB2 | 0.28860895 |
| 141 | CSNK1D | 0.28687938 |
| 142 | DYRK2 | 0.28403450 |
| 143 | PRKG1 | 0.28283254 |
| 144 | MAP3K4 | 0.27904690 |
| 145 | RET | 0.26675726 |
| 146 | NEK1 | 0.26631141 |
| 147 | CSNK1E | 0.21433009 |
| 148 | MAP3K1 | 0.20639781 |
| 149 | MAP3K11 | 0.20541083 |
| 150 | DAPK3 | 0.17634878 |
| 151 | FGFR4 | 0.17370234 |
| 152 | MAP3K9 | 0.17207431 |
| 153 | CDC42BPA | 0.16223112 |
| 154 | ERBB2 | 0.15894605 |
| 155 | ACVR1B | 0.13565885 |
| 156 | YES1 | 0.12973418 |
| 157 | AKT1 | 0.11891203 |
| 158 | RPS6KB1 | 0.10595894 |
| 159 | DAPK1 | 0.09668638 |
| 160 | ALK | 0.09415971 |
| 161 | TAOK3 | 0.09268392 |
| 162 | CDK6 | 0.09020141 |
| 163 | MAPK14 | 0.08067150 |
| 164 | PDGFRA | 0.06840919 |
| 165 | MAPK10 | 0.06361524 |
| 166 | CDK9 | 0.06278332 |
| 167 | AURKA | 0.05522875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.93374401 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.63064985 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.21453589 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.01259164 |
| 5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.82012528 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.70472530 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56501128 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.48566547 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.47607498 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41102768 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.98358449 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95219055 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.84578740 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.70767274 |
| 15 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.69663509 |
| 16 | Prion diseases_Homo sapiens_hsa05020 | 1.68313064 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.68239335 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.66793159 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.65017439 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.64246199 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62791382 |
| 22 | Mineral absorption_Homo sapiens_hsa04978 | 1.56948210 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.51454088 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.48301410 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.46255737 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.45923745 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.38550011 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36563639 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29734321 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.27176174 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25637707 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.23679446 |
| 33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.21299691 |
| 34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.19381451 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17781490 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.16111992 |
| 37 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.12627996 |
| 38 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11307154 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06408888 |
| 40 | * Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.06225278 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06224002 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04958486 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.04707382 |
| 44 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.03339838 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01431379 |
| 46 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.98831679 |
| 47 | Prostate cancer_Homo sapiens_hsa05215 | 0.96443692 |
| 48 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.95805968 |
| 49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94619564 |
| 50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.94078674 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91493472 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88721336 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 0.88484439 |
| 54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.87414352 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86791596 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86698264 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 0.86627742 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84226824 |
| 59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.83433118 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83208299 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82200654 |
| 62 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.82058038 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81383768 |
| 64 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.80710565 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.77417133 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.77227997 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74087702 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73258958 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72889293 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.72037100 |
| 71 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70397712 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.70320293 |
| 73 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.69623663 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69162418 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68790854 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68687892 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64454487 |
| 78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64436504 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64394134 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62869032 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62448592 |
| 82 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60567301 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59455227 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59180050 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58157625 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.57780273 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55796869 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55679252 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54415047 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.53850204 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53686257 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53498231 |
| 93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52103734 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50884050 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50392372 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50273318 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49611025 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.49274950 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49003705 |
| 100 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48406422 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47583088 |
| 102 | Renin secretion_Homo sapiens_hsa04924 | 0.46470820 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45838230 |
| 104 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.44567697 |
| 105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.43768712 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43669383 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42881940 |
| 108 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42720716 |
| 109 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42408601 |
| 110 | Axon guidance_Homo sapiens_hsa04360 | 0.42408031 |
| 111 | Insulin secretion_Homo sapiens_hsa04911 | 0.41670738 |
| 112 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.41639081 |
| 113 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.41429016 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41016441 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38651223 |
| 116 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38148336 |
| 117 | Long-term potentiation_Homo sapiens_hsa04720 | 0.37242501 |
| 118 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36834440 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36527309 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36188149 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35993452 |
| 122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35967887 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.35931629 |
| 124 | Gap junction_Homo sapiens_hsa04540 | 0.34357470 |
| 125 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34142115 |
| 126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32891339 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32776837 |
| 128 | Circadian entrainment_Homo sapiens_hsa04713 | 0.31595949 |
| 129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31322729 |
| 130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31214571 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31025013 |
| 132 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30978709 |
| 133 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30512236 |
| 134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.28908331 |
| 135 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.26184497 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25756173 |

